DGMRF would like to extend its utmost and sincere gratitude for their extremely generous support to:
Rajesh and Emily Alva
Prince and Princess Pierre and Sylvia d’Aremberg
Glenn and Debbie August
Lorenz and Géraldine Baümer
Johan and Eliane Beckman
Jacques and Katharina Bouhet
Bruno and Helen Bouygues
Augustin and Stephanie de Buffevent
Josephine de Chazournes
Prince and Princess Alex and Patricia Farman-Farmaian
Sarah de Goldschmidt-Rothschild
Baroness Catherine de Gunzburg
Baron and Baroness Charles and Nathalie de Gunzburg
Baron and Baroness Dimitri and Shawn de Gunzburg
Baron and Baroness Jean and Terry de Gunzburg
Baron and Baroness Gerard and Brooke de Gunzburg
John and Marie-Christine Heimann
Shiv and Urvashi Khemka
Prince and Princess Alexandre and Astrid
Gian Matteo Lo Faro
Marc and Mara Hank Moret
William and Clémence von Mueffling
My Tribute Gift Foundation
Prince and Princess Charles-Louis and Ileana d’Orleans
François and Caroline Reyl
Baron and Baroness David and Olympia de Rothschild
Edmond and Marielle Safra
Sandell Asset Management
Thomas and Ximena Sandell
Stephen and Christine Schwarzman
François-Xavier de Seze
Jeffrey and Susan Stern
Pierre-Olivier and Alexandra Sur
Guilherme and Benjamine Valle
Count Guy de la Tour du Pin Verclause
Ashi and Nita Varia
Gerhard and Elisabeth Walch
Baron and Baroness Gerard and Sylvia de Waldner
Stylianos and Sofia Zavvos
It is thanks to the extraordinary consistant contribution of donors like William & Clémence von Mueffling and Thomas & Ximena Sandell that people suffering from this orphan and rare incurable blood cancer can have the hope for a better future.
Even though new drugs have been developed and did extend survival rate over the last ten years, no cure has yet been found. Non-profit early stage research is vital to help laboratories and expert clinical teams add and/or create a brand new future pipeline of therapeutics (including by extending the current combination of existing compounds), with the goal to ultimately find new molecules to reach for a cure and if not, to improve life quality and expectancy for patients.
This is especially true in this current difficult economic and social environment which affects innovative research and start-up ideas in particular. Research is increasingly dependent on the kindness, generosity, philanthropy and selflessness of donors like William and Clémence von Mueffling and yourselves.
Mr. de Gunzburg committed to also financing all expenses (direct and indirect) needed by DGRMF to get started and operate (lawyers’ fees, offices, employees, etc.), so that any donation would entirely go straight fully to research.
The de Gunzburg Myeloma Research Foundation (the “DGMRF”) is a non-profit private foundation established in March 2012 under the meaning of section 509(a) of the Code. DGMRF applied for tax-exempt status in May 2012 under section 501(c)(3) of the Internal Revenue Code, and received its formal tax exempt status from Federal income tax in August 2012. Tax-exempt status having been granted, donations from US, Canadian and Israeli donors are deductible under section 170 of the code for income tax purposes to the extent permitted by the law. DGMRF is also qualified to receive tax deductible bequests, devises transfers or gifts under section 2055, 2106 or 2522 of the Code. The de Gunzburg Myeloma Research Foundation will exclusively select and finance research programs within hospitals and laboratories in the US only, which have experienced teams and which entities also benefit of the 501(c)(3) non-profit tax deductible status. The de Gunzburg Myeloma Research Foundation hereby also confirms that no goods or services will be provided in consideration for your gift. Upon donation, a formal thank you letter will be sent to the donors to serve as tax deductible receipt.
Thank you so much for your inspiring support of this cause, which will provide real hope and help to hundreds of thousands of people worldwide battling this disease.
Support early stage fundamental research and DGMRF by buying our gear:
- Hats: $30
- T-Shirts: $50
- Umbrella: $70
Please send us your selection with color (for hats), number of items and size (t-shirts) by e-mail at Contact@Gunzburg-Myeloma.org.
Thank you for your support!
For make donations to DGMRF, please either
- Make checks (to the order of “DGMRF” or “de Gunzburg Myeloma Research Foundation”)
or Wire Transfers:
- Luis Nunes
- Citibank NA
- 460 Park Avenue
- New York NY 10022 – USA
The Foundation’s Accountants are Deloitte, and
The Foundation’s Auditors are WeiserMazars.
Collection and use of information:
We collect two kinds of information: site usage data, which is not linked to individual visitors, and individually identifiable information.
Site usage data:
Our web server automatically recognizes and collects the domain name of each visitor to our website. We collect information about visitors to our site such as the number of visitors, what pages they access, and the length of their visit. This information is exclusively used in aggregate form in order to simply manage our website and improve its content.
Individually identifiable information:
We collect individually identifiable information about you when you choose to share information about yourself, for example, when you make a donation, request information, post a blog or sign up for our mailing list. This information may include personal information such as your e-mail address, postal address, and telephone number.
Individually identifiable information is used to provide you with information or to deliver the service you have requested. If you provide your e-mail address, postal address, or telephone number, you may receive periodic contacts from us. You will always have the opportunity to change the way we contact you or unsubscribe from future communications.
Some portions of our site (such as the comments section of our blog) are interactive and allow users to upload information for public consumption. Users may choose to share experiences, give advice, and connect with others. Please remember that chat rooms, message boards, and personal pages are public forums and personal information disclosed there will be seen by others. In addition, please exercise caution when posting information or providing information about yourself to others, especially contact information such as street address, telephone number, or e-mail address.
Sharing Information with Others:
DGMRF does not share its mailing list or any personal information with any other organization. Should this policy change, we will provide individuals the opportunity to indicate their preferences about whether or not their personal information may be shared.
We occasionally send out an e-mail newsletter and direct e-mail communications to individuals on the DGMRF’s mailing list, provided you gave us your information and asked for it, in order to highlight news and information about our organization. All e-newsletters and direct e-mail communications have easy-to-follow unsubscribe instructions at the bottom of each e-mail. In addition, you can elect not to receive communications from us by contacting us through any method listed at the bottom of this page.
Links to Other Sites:
Our website has a number of security measures in place to protect against the loss, misuse, or alteration of the information under our control. Our computer systems have restricted access limited only to those persons and organizations necessary to its proper functioning. This access applies to all electronic and physical security measures. Our servers are located in a locked, secure environment.
Online donations to DGMRF are collected through partly Authorize.Net and PayPal. Authorize.Net and PayPal use industry-leading secure technologies such as Secure Sockets Layer (SSL) for Authorized.Net to keep highly sensitive data including your credit card information as secure as possible.
The de Gunzburg Myeloma Research Foundation (“DGMRF”) was established to finance research programs from and within third parties’ leading medical institutions. The DGMRF is a non-profit private foundation which has tax exempt status under section 501(c)(3) of the United States of Americas’ Internal Revenue Code.
Any information and/or data available on the website of the DGMRF (the “Website”) is accessible to anybody. This Website does not purport to contain all the information (the “Information”) to understand and/or evaluate all of the factors regarding myeloma. Any reader hereof should conduct his/her own investigation and analysis on the disease, including as the case may be, based on the specificities relating to the potential myeloma patient.
The DGMRF has not independently verified the Information contained on the Website. The DGMRF makes no representation or warranty of any kind, express or implied, as to the accuracy or completeness of the Information or any other written or oral communication transmitted or made available. The DGMRF and their representatives hereby expressly disclaim any and all liability based, in whole or in part, on such Information, including without limitation regarding (a) the quality, accuracy, timeliness, or completeness of the Information, and (b) fitness for a particular purpose. In no event shall DGMRF be liable for any direct or indirect, incidental, exemplary, special, punitive, or consequential damages relating to the use of this Information.